Kemwell Biopharma

The Biosimilar council held a conference in which academic experts and number of government officials were present to discuss the landscape and future of Biosimilar industry.   The main focus of this conference was basically dedicated to the patients, public, and education of health professionals.   The effectiveness and safety of the Biosimilar should be known to the public and to spread this awareness,    the meeting was held in the year 2017. There are mainly five reasons due to which it is the right time to lead and focus on Biosimilar ·          Effective and safe The most important factor during the production of Biosimilar is that this can be helpful in the approval of the FDA.   It uses the same kind of mechanism for the particular biological brand and it can be used as a Biosimilar working. The FDA always requires the Biosimilar manufacturers to use safe methods and monitoring technique to check vario...

Contract manufacturing got huge popularity and growth in recent few years and pharmaceutical industries are focusing on it because of its lots of advantages. Contract manufacturing is the process where the companies prefer outsourcing for the manufacturing and production of pharmaceutical products. In the market, many companies are providing the solutions for contract manufacturing for pharmaceutical companies in this industry. There are several good reasons behind the preference of contract manufacturing by the pharmaceutical companies. Whether it is about the manufacturing of high-quality medical products or reducing the manufacturing cost, Outsourcing and contract manufacturing companies can offer these benefits for pharmaceutical companies. It is for sure that the pharmaceutical industry will continue to rely on contract development and manufacturing because of its bunch of benefits. As per the reports, the use and requirement of contract manufacturing is increasing...

Since the first use of biologics, it has grown to become a crucial tool in modern medicine. As the technology is getting better and there is a big advancement in biological research and production, the new life-saving treatment methods and drugs are available at the present time. Biologics are available as innovative treatment solutions for the patients who are affected by life-threatening and debilitating diseases and looking for proper treatment solution with the best medical products and tools. biologics are made with the use of living tissues or cells and it is very complex drug for serious health-related issues. As you know, biologics are available at expensive cost and there is a limited access of these medical products for the patients. Biosimilars are available as biologic medicine similar to the previously approved reference biologic that is available currently on the market. These drugs are made to use in the same way as biologics and available as a copy with the ...

When the need for drugs is increasing in the market, the important of CMOs is increasing in the market as they provide and supply necessary products to the customers with best perfectly engineered products. Irrespective of the growing collaboration between pharmaceutical companies and CMOs, people still want to know about the benefits of having a connection with contract manufacturing organizations . Here are some of the reasons due to which the importance of CMOs is increasing in the market today: Additional production capacity Every pharmaceutical industry can gain significant operational benefits by taking help of the CMOS because they can help in satisfying the demand of a particular drug. The pharma company won’t have to spend excess money and different resources to meet the particular demand of Contract Formulation Development because the CMOs will be always there to assist with the goals. The new pharma companies can be highly benefitted by taking help of the CMOS...

Despite the clinical trials of drugs, RWE has become one of the most important strategies which can help researchers to know about the performance of the product and the whole information outside the clinical trials. Whether it includes billing databases and disease registries or it includes electronic health records, Real-World Evidence can help to know the results of a medicine. There are some factors with which RWE can be helpful and here are some of these points which can provide that RWE is highly important in knowing the outcome of drugs and much more: ·          The effect of environmental factors on treatment ·          Knowing drug interactions which can be safely performed ·          Observed advantages of medicines ·          Performance of drug against medicines which were approved in past. · ...

Most of the CMOs around the world are planning to make an investment in the capacity so that the requirements of the pharmaceutical companies can be met. In single-use investment, both upstream and downstream procedures like Purification technology and bioreactors are used. The development of new expression systems with better capabilities are getting established by the CMOs. The companies are also making an investment in the microbioreactors as it can help in the improvisation of biopharmaceutical develm op ent and enhancement in the speed of production.   biopharmaceutical develm op ent   Since the monoclonal antibody products are introduced in the market, they are known to be one of the dominant components of the biopharmaceutical market. During the development of monoclonal antibodies, the greatest challenge faced by the company is securing the manufacturing capacity. It is necessary that both the commercial and clinical capacity is secured in a comp...

Biologics Biologics are medicine derived from living cells and constituents of human bodies like Ribo Nucleic Acid (RNA), Deoxyribo Nucleic Acid (DNA), or hormones. The first biologic developed for therapeutic use was insulin. Currently, biologics have become the fastest growing drugs in the Pharmaceutical Industry with around 300 biologics available for human consumption. Biologics are widely used to treat a vast number of diseases including cancer and rheumatoid arthritis. They are better in targeting cancer producing cells due to its efficient binding nature. The Pharma Companies estimate that by the year 2019, sales of biologics would generate a revenue of approximately USD220 billion annually. However, only a small fraction of biologics, especially the monoclonal antibodies (mAbs) is going to create most of this revenue. Entry of Biosimilar in Pharmaceutical Industry Biosimilar, as the name suggests, are “highly similar” to one of the FDA-approv...